Improving progression-free and overall survival in patients with cancer: a potential role for bisphosphonates

By Lipton Allan  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. : 749-762

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 immunogen does not appear to improve HIV progression-free survival

By  

Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

APC 8015 may improve survival duration in prostate cancer

By  

Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival

By Cohen Jonathon B.   Geyer Susan M.   Lozanski Gerard   Zhao Weiqiang   Heerema Nyla A.   Hall Nathan C.   Nagar Veena A.   Hemminger Jessica A.   Jones Jeffrey A.   Porcu Pierluigi   Christian Beth A.   Baiocchi Robert A.   Maddocks Kami J.   Flynn Joseph M.   Devine Steven M.   Blum Kristie A.  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1677-1685

Blackwell Publishing

Access to resources Recommend Favorite

Intermediate clinical endpoints: A bridge between progression-free survival and overall survival in ovarian cancer trials

By Matulonis Ursula A.   Oza Amit M.   Ho Tony W.   Ledermann Jonathan A.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1737-1746

Blackwell Publishing

Access to resources Recommend Favorite